Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 2, 2011, Pages 375-384

  Eisenhofer, Graeme ^a   Timmers, Henri J ^b   Lenders, Jacques W M ^a,b   Bornstein, Stefan R ^a   Tiebel, Oliver ^a   Mannelli, Massimo ^c   King, Kathryn S ^e   Vocke, Cathy D ^d   Linehan, W Marston ^d   Bratslavsky, Gennady ^d   Pacak, Karel ^e  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF FLORENCE   (Italy)

^d NATIONAL CANCER INSTITUTE   (United States)

^e EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CATECHOLAMINE; METADRENALIN; SUCCINATE DEHYDROGENASE; VON HIPPEL LINDAU PROTEIN;

ADOLESCENT; ADRENALIN BLOOD LEVEL; ADULT; AGE AT DIAGNOSIS; AGED; ARTICLE; CHILD; CONTROLLED STUDY; EARLY DIAGNOSIS; ENDOCRINE TUMOR; FEMALE; GENE MUTATION; GENETIC DISORDER; GERM LINE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIPLE ENDOCRINE NEOPLASIA; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2; ONSET AGE; PARAGANGLIOMA; PHENOTYPE; PHEOCHROMOCYTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; TUMOR DIAGNOSIS; TUMOR LOCALIZATION;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADRENAL GLANDS; ADULT; AGED; AGED, 80 AND OVER; AGING; CATECHOLAMINES; CHILD; DATABASES, FACTUAL; EPINEPHRINE; FEMALE; GENETIC TESTING; HUMANS; MALE; METANEPHRINE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; MUTATION; NEUROFIBROMATOSIS 2; PHENOTYPE; PHEOCHROMOCYTOMA; RETROSPECTIVE STUDIES; SUCCINATE DEHYDROGENASE; VON HIPPEL-LINDAU DISEASE; YOUNG ADULT;

EID: 79251530519     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-1588     Document Type: Article

References (28)

1. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, Januszewicz A, Eng C, Smith WM, Munk R, Manz T, Glaesker S, Apel TW, Treier M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M, Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Peçzkowska M, Szmigielski C, Eng C 2002 Germ-line mutations in non-syndromic pheochromocytoma. N Engl J Med 346:1459-1466
2. Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, Chabre O, Chamontin B, Delemer B, Giraud S, Murat A, Niccoli- Sire P, Richard S, Rohmer V, Sadoul JL, Strompf L, Schlumberger M, Bertagna X, Plouin PF, Jeunemaitre X, Gimenez-Roqueplo AP 2005 Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 23:8812-8818 (Pubitemid 46211527)
3. Mannelli M, Castellano M, Schiavi F, Filetti S, Giacche M, Mori L, Pignataro V, Bernini G, Giache V, Bacca A, Biondi B, Corona G, Di Trapani G, Grossrubatscher E, Reimondo G, Arnaldi G, Giacchetti G, Veglio F, Loli P, Colao A, Ambrosio MR, Terzolo M, Letizia C, Ercolino T, Opocher G 2009 Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. J Clin Endocrinol Metab 94:1541-1547
4. Kimura N, Miura Y, Nagatsu I, Nagura H 1992 Catecholamine synthesizing enzymes in 70 cases of functioning and non-functioning phaeochromocytoma and extra-adrenal paraganglioma. Virchows Arch A Pathol Anat Histopathol 421:25-32
5. Eisenhofer G, Lenders JW, Goldstein DS, Mannelli M, Csako G, Walther MM, Brouwers FM, Pacak K 2005 Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines. Clin Chem 51:735-744 (Pubitemid 40463925)
6. Eisenhofer G, Walther MM, Huynh TT, Li ST, Bornstein SR, Vortmeyer A, Mannelli M, Goldstein DS, Linehan WM, Lenders JW, Pacak K 2001 Pheochromocytomas in von Hippelhyphen Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. J Clin Endocrinol Metab 86:1999-2008 (Pubitemid 32472911)
7. Eisenhofer G, Huynh TT, Pacak K, Brouwers FM, Walther MM, Linehan WM, Munson PJ, Mannelli M, Goldstein DS, Elkahloun AG 2004 Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippelhyphen Lindau syndrome. Endocr Relat Cancer 11:897-911 (Pubitemid 40065561)
8. Bayley JP, Kunst HP, Cascon A, Sampietro ML, Gaal J, Korpershoek E, Hinojar-Gutierrez A, Timmers HJ, Hoefsloot LH, Hermsen MA, Suárez C, Hussain AK, Vriends AH, Hes FJ, Jansen JC, Tops CM, Corssmit EP, de Knijff P, Lenders JW, Cremers CW, Devilee P, Dinjens WN, de Krijger RR, Robledo M 2010 SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. Lancet Oncol 11:366-372
9. Qin Y, Yao L, King EE, Buddavarapu K, Lenci RE, Chocron ES, Lechleiter JD, Sass M, Aronin N, Schiavi F, Boaretto F, Opocher G, Toledo RA, Toledo SP, Stiles C, Aguiar RC, Dahia PL 2010 Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat Genet 42:229-233
10. Burnichon N, BrièreJJ, Libé R, Vescovo L, RiviéreJ, Tissier F, Jouanno E, Jeunemaitre X, Bénit P, Tzagoloff A, Rustin P, Bertherat J, Favier J, Gimenez-Roqueplo AP 2010 SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet 19:3011-3020
11. Eisenhofer G, Goldstein DS, Sullivan P, Csako G, Brouwers FM, Lai EW, Adams KT, Pacak K 2005 Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. J Clin Endocrinol Metab 90:2068-2075 (Pubitemid 40586241)
12. Lenders JW, Eisenhofer G, Armando I, Keiser HR, Goldstein DS, Kopin IJ 1993 Determination of metanephrines in plasma by liquid chromatography with electrochemical detection. Clin Chem 39:97-103 (Pubitemid 23034964)
13. Cascón A, Pita G, Burnichon N, Landa I, López- Jiménez E, Montero-Conde C, Leskelä S, Leandro-Garcia LJ, Letón R, Rodríguez- Antona C, Diaz JA, López-Vidriero E, González-Neira A, Velasco A, Matias-Guiu X, Gimenez-Roqueplo AP, Robledo M 2009 Genetics of pheochromocytoma and paraganglioma in Spanish patients. J Clin Endocrinol Metab 94:1701-1705
14. Walther MM, Herring J, Enquist E, Keiser HR, LinehanWM1999 von Recklinghausen's disease and pheochromocytomas. J Urol 162:1582-1586
15. Casanova S, Rosenberg-Bourgin M, Farkas D, Calmettes C, Feingold N, Heshmati HM, Cohen R, Conte-Devolx B, Guillausseau PJ, Houdent C, Bigorgne JC, Boiteau V, Caron J, Modigliani E 1993 Phaeochromocytoma in multiple endocrine neoplasia type 2 A: survey of 100 cases. Clin Endocrinol (Oxf) 38:531-537 (Pubitemid 23153416)
16. Pomares FJ, Canas R, Rodriguez JM, Hernandez AM, Parrilla P, Tebar FJ 1998 Differences between sporadic and multiple endocrine neoplasia type 2A phaeochromocytoma. Clin Endocrinol (Oxf) 48:195-200 (Pubitemid 28091051)
17. Ricketts CJ, Forman JR, Rattenberry E, Bradshaw N, Lalloo F, Izatt L, Cole TR, Armstrong R, Kumar VK, Morrison PJ, Atkinson AB, Douglas F, Ball SG, Cook J, Srirangalingam U, Killick P, Kirby G, Aylwin S, Woodward ER, Evans DG, Hodgson SV, Murday V, Chew SL, Connell JM, Blundell TL, Macdonald F, Maher ER 2010 Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Hum Mutat 31:41-51
18. Pollard PJ, El-Bahrawy M, Poulsom R, Elia G, Killick P, Kelly G, Hunt T, Jeffery R, Seedhar P, Barwell J, Latif F, Gleeson MJ, Hodgson SV, Stamp GW, Tomlinson IP, Maher ER 2006 Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations. J Clin Endocrinol Metab 91:4593-4598 (Pubitemid 44833443)
19. Lee S, Nakamura E, Yang H, Wei W, Linggi MS, Sajan MP, Farese RV, Freeman RS, Carter BD, Kaelin Jr WG, Schlisio S 2005 Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. Cancer Cell 8:155-167 (Pubitemid 41132744)
20. Tischler AS 2006 Molecular and cellular biology of pheochromocytomas and extra-adrenal paragangliomas. Endocr Pathol 17:321-328 (Pubitemid 47012399)
21. Schlisio S, Kenchappa RS, Vredeveld LC, George RE, Stewart R, Greulich H, Shahriari K, Nguyen NV, Pigny P, Dahia PL, Pomeroy SL, Maris JM, Look AT, Meyerson M, Peeper DS, Carter BD, Kaelin Jr WG 2008 The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes Dev 22:884-893 (Pubitemid 351482842)
22. Adams MS, Bronner-FraserM2009 Review: the role of neural crest cells in the endocrine system. Endocr Pathol 20:92-100
23. Parlato R, Otto C, Tuckermann J, Stotz S, Kaden S, Gröne HJ, Unsicker K, Schutz G 2009 Conditional inactivation of glucocorticoid receptor gene in dopamine-beta-hydroxylase cells impairs chromaffin cell survival. Endocrinology 150:1775-1781
24. Knudson Jr AG 1971 Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823
25. Bryant J, Farmer J, Kessler LJ, Townsend RR, Nathanson KL 2003 Pheochromocytoma: the expanding genetic differential diagnosis. J Natl Cancer Inst 95:1196-1204 (Pubitemid 37069549)
26. Dannenberg H, van Nederveen FH, Abbou M, Verhofstad AA, Komminoth P, de Krijger RR, Dinjens WN 2005 Clinical characteristics of pheochromocytoma patients with germline mutations in SDHD. J Clin Oncol 23:1894-1901 (Pubitemid 46211367)
27. Bornstein SR, Gimenez-Roqueplo AP 2006 Genetic testing in pheochromocytoma: Increasing importance for clinical decision-making. Ann NY Acad Sci 1073:94-103 (Pubitemid 44912002)
28. Erlic Z, Rybicki L, Peczkowska M, Golcher H, Kann PH, Brauckhoff M, Mussig K, Muresan M, SchäfflerA, Reisch N, Schott M, Fassnacht M, Opocher G, Klose S, Fottner C, Forrer F, Plockinger U, Petersenn S, Zabolotny D, Kollukch O, Yaremchuk S, Januszewicz A, Walz MK, Eng C, Neumann HP 2009 Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients. Clin Cancer Res 15:6378-6385